Ad image
Washington DC's Top Rated Weed Delivery

Psychedelics, Initiative 81, Mushrooms

 
Are you aware of psilocybin and ibogaine? Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. Most commonly people think of the hallucinogenic properties of some mushrooms. There are also fungi that alter mood, perception, and cognitive function.  

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations

In this week’s episode, Joe and Alexa talk about the excitement brewing around

A Deeper Look at Psychedelics Anonymous

Building a psychedelic community isn’t easy. Psychedelics are emerging into a landscape

“How to Change Your Mind” Netflix Docuseries: Does it Change Yours?

Episode 3: MDMA Short take: an episode for the evidence-based mind Long

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study

In this episode, Victoria hosts a bit of a microdosing roundtable, speaking

Protests in Ottawa for Access to Psychedelic Medicine

TheraPsil Organizes Protest in Ottawa Non-profit group TheraPsil has brought a group of

Our Take on “The Trip Journal” for Psychedelic Integration Success

Journaling Your Way Through Psychedelic Experiences No one knows you better than

MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

MAPS PBC has completed its second Phase 3 study of MDMA-Assisted Therapy

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

This week features David Drapkin, Joe Moore (for the first part), and

When Will MDMA be Approved by the FDA?

On November 17th, the Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit

Psychedelic Holiday Gift Guide: Our Top Picks

This isn’t your average holiday gift guide. You won’t find personalized picture

PT374 – Personalizing Psychedelic Integration

In this episode, Kyle interviews psychologist, psychotherapist, author, and certified Holotropic Breathwork®

Wonderland 2022 Recap: Algernon Pharmaceuticals

With Wonderland 2022 still fresh in our rear-view mirrors, let’s take a moment

Wonderland 2022: Setting a New Precedent for Psychedelic Conferences

From festivals to spiritual ceremonies, connection is the core nature of any

Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing for atai’s PCN-101 Results; Tactogen Launches Community Funding Round

Psilocybin is “an MDMA-based medicine”, According to Conservative MP  |  In response

Why Did Psychedelics Relieve My Chronic Pain?

In part 2 of the article, “Surprising Results: Psilocybin Trial for Depression

MAPS Completes Second Phase 3 MDMA Trial

    Top-line data expected in the first quarter of 2023 Data

Mastering Microdosing by Paul Austin: Book Preview

Deeper Sense of Connection: {Paul Austin’s Microdosing Story} Like so many others,

Interview | Elliot Marseille, Global Initiative for Psychedelic Science Economics (GIPSE)

Coming of age in Berkeley during the height of the counterculture, it

PT368 – Ketamine, Group Work, and the Power of Just Being There

In this episode, Kyle interviews Dr. Steven Radowitz: Medical Director at Nushama,

Psychedelic Therapy and the Wabi Sabi Way

When I was seeking treatment for my depression and childhood trauma, I

Are Magic Mushrooms Safe? — 🍄 Psychedelic Tips

Taking magic mushrooms is becoming more and more mainstream due to the

My Experience at Tandava Retreats: A Full Review

What I Loved About Tandava In a nutshell, here’s what I absolutely

Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences

5th Annual Neuropsychiatric & Psychedelics Drug Development Summit in Boston, MA on

Free Webinar — Psychedelic Autism: A Brief Intro and Q&A with Aaron Orsini

During this webinar, Aaron will provide a very brief introduction to the

A Deeper Look at Atai Life Sciences’ R&D Day

Today, atai Life Sciences (Nasdaq: ATAI) held its much anticipated R&D Day, where

San Francisco Most Recent City To Decriminalize Psychedelics

In another win for the psychedelic community, San Francisco lawmakers have officially

How I Grew My Own Mushrooms for Microdosing

Fruiting In this third stage of the mushroom cultivation process, the aim

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (NASDAQ: REUN,

PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules

In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle